E2F1 and acute myeloid leukemia: Importantly, when the patients were sorted in accordance with FAB classification, we observed a higher survival rate among patients with the most aggressive low differentiated subtypes of AML M0, M1, M2, revealing relatively high E2F1 expression (Figure 4G).